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Suppression of mitochondrial 
oxygen metabolism mediated 
by the transcription factor HIF-1 
alleviates propofol-induced cell 
toxicity
Chisato Sumi1,2, Akihisa Okamoto2, Hiromasa Tanaka2, Munenori Kusunoki1,2, Tomohiro 
Shoji1,2, Takeo Uba1,2, Takehiko Adachi3, Teppei Iwai2, Kenichiro Nishi2, Hiroshi Harada4,5, 
Hidemasa Bono  6, Yoshiyuki Matsuo2 & Kiichi Hirota  2
A line of studies strongly suggest that the intravenous anesthetic, propofol, suppresses mitochondrial 
oxygen metabolism. It is also indicated that propofol induces the cell death in a reactive oxygen species 
(ROS)-dependent manner. Because hypoxia-inducible factor 1 (HIF-1) is a transcription factor which is 
involved in cellular metabolic reprogramming by modulating gene expressions of enzymes including 
glycolysis pathway and oxygen utilization of mitochondria, we examined the functional role of HIF-1 
activity in propofol-induced cell death. The role of HIF-1 activity on oxygen and energy metabolisms 
and propofol-induced cell death and caspase activity was examined in renal cell-derived RCC4 cells: 
RCC4-EV cells which lack von Hippel-Lindau protein (VHL) protein expression and RCC4-VHL cells, 
which express exogenous VHL, and in neuronal SH-SY5Y cells. It was demonstrated that HIF-1 is 
involved in suppressing oxygen consumption and facilitating glycolysis in cells and that the resistance 
to propofol-induced cell death was established in a HIF-1 activation-dependent manner. It was also 
demonstrated that HIF-1 activation by treatment with HIFα-hydroxylase inhibitors such as n-propyl 
gallate and dimethyloxaloylglycine, alleviated the toxic effects of propofol. Thus, the resistance 
to propofol toxicity was conferred by HIF-1 activation by not only genetic deletion of VHL but also 
exposure to HIFα-hydroxylase inhibitors.
Propofol (2,6-diisopropylphenol) is used for anesthesia in operating theaters and for sedation in intensive care 
units around the world1. Propofol is recognized as a safe and effective drug. However, it can cause a rare but 
severe complication, especially in patients receiving high doses for prolonged periods. This syndrome is known 
as propofol infusion syndrome2–4. Although the morbidity of the syndrome is approximately 1%, even among 
critically ill patients, mortality is >50%4. Thus, this syndrome is one of the most significant issues to be addressed 
in the field of critical care medicine.
We previously demonstrated that clinically relevant concentrations of propofol used within a clinically rele-
vant exposure time suppressed mitochondrial function, induced the generation of reactive oxygen species (ROS), 
and caused metabolic reprogramming from oxidative phosphorylation (OXPHOS) to glycolysis by targeting 
mitochondrial complexes I, II and III5. In addition, we showed that the local anesthetic, lidocaine, induced ROS 
generation, which was attenuated by forced activation of hypoxia-inducible factor 1 (HIF-1)6.
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HIF-1 is a transcription factor that functions as a master regulator of oxygen homeostasis7,8. This heterodimeric 
protein is composed of a constitutively expressed HIF-1β subunit and an O2-regulated HIF-1α subunit under 
normoxic conditions. HIF-1α is subjected to prolyl hydroxylation by oxygenases, which utilize O2 as a substrate9. 
Hydroxylation modification is required for binding of the von Hippel-Lindau (VHL) protein, which targets HIF-1α 
for ubiquitination and proteasomal degradation10. Thus, even under normoxic conditions, hydroxylase inhibitors 
such as dimethyloxaloylglycine (DMOG) and n-propyl gallate (nPG) can activate HIF-16,11–13. Accordingly, the 
genetic ablation of VHL also activate HIF-1 even under normoxic conditions10. Intriguingly, mitochondrial func-
tion can be regulated by HIF-114–16. OXPHOS is regulated by several mechanisms, including substrate availability. 
Pyruvate is one of the substrates determining OXPHOS and electron transport in mitochondria. Pyruvate is con-
verted to acetyl-CoA by the pyruvate dehydrogenase complex; this is regulated by pyruvate dehydrogenase kinases, 
the expression of which is regulated by HIF-117. Thus, HIF-1 actively regulates the oxygen metabolism of the cells 
by coordinating mitochondrial function. Thus the efficient use of available oxygen explain how HIF-1 activation 
suppresses the generation of harmful byproducts such as ROS17–19.
In this study, we investigate the role of HIF activation on propofol-induced apoptosis in renal cell-derived 
RCC4 cells and neuronal SH-SY5 cells, and demonstrate that activation of HIF-1 ameliorates propofol toxicity by 
modulating mitochondrial function and ROS generation.
Results
RCC4-EV cells are resistant to propofol-induced cell. It is reported that RCC4-EV cells do not express 
VHL protein and they therefore constitutively express HIF-1α, a regulatory subunit of HIF-1 even under nor-
moxic (20% O2) conditions10. In contrast, RCC4-VHL cells express exogenous VHL protein, and HIF-1α expres-
sion is therefore regulated in an oxygen tension-dependent manner. To determine the dose- and time-response 
relationship between propofol treatment and cell death, we treated RCC4-EV and RCC4-VHL cells with the 
indicated doses of propofol for 6 h (Fig. 1) under 20% O2 conditions. Effect of propofol on the cell death of 
RCC4-EV cells and RCC4-VHL cells were examined by flow cytometry with PI and FITC-conjugated annexin 
V staining (Fig. 1a). The cell death following treatment with 50 µM propofol for 6 h was significantly suppressed 
in RCC4-EV cells compared to RCC4-VHL cells (Fig. 1b). Next, we investigated the caspases activations under 
propofol treatment. Concentrations > 50 µM propofol induced caspase 9 activation within 6 h. 50 µM and 100 µM 
propofol induced caspase 9 activation significantly differentially in RCC4-EV cells and RCC4-VHL cells (Fig. 2a). 
Next, caspase 3/7 activity was evaluated following exposure of both RCC4-VHL and RCC4-EV cells to propofol 
for 6 h. Similarly to caspase 9, a significant difference in caspase 3/7 activity was detected between RCC4-EV cells 
and RCC4-VHL cells following propofol treatment (Fig. 2b).
HIF-1 is activated in RCC4-EV cells under 20% O2 conditions. HIF-1 activation was investigated in 
RCC4-VHL and RCC4-EV cells cultured under normoxic (20% O2) and hypoxic (1% O2) conditions. The protein 
expression levels of HIF-1α and HIF-1β were assayed by immunoblot analysis (Fig. 3a). Consistent with a previous 
report10, HIF-1α was constitutively expressed in RCC4-EV cells, even in the presence of 20% O2, at levels compara-
ble to those observed in RCC4-VHL cells cultured in the presence of 1% O2. HIF-1β expression was stable in both 
cell types under both O2 levels. Consistent with HIF-1α protein expression findings, the mRNA levels of down-
stream genes including glucose transporter 1 (glut1), lactate dehydrogenase A (ldha) and pyruvate dehydrogenase 
kinase 1(pdk1) were higher in RCC4-EV cells than in RCC4-VHL cells under 20% O2 conditions (Fig. 3b).
Next, the RCC4-EV and RCC4-VHL cell growth rates were examined using the MTS assay (Fig. 3c). No sig-
nificant difference in the cell growth rate of RCC4-VHL and RCC4-EV cells was found. However, RCC4-EV cells 
had a higher level of ATP, as compared with the RCC4-VHL cells (Fig. 3d).
HIF-1 activation is required for resistance to propofol-induced cell death. Treatment of RCC4-EV 
cells with the HIF inhibitor, YC-1, reduced the expression of downstream genes such as glut1, ldha and pdk1 in 
RCC4-EV cells but not in RCC4-VHL cells (Fig. 4a). The YC-1 treatment also significantly increased caspase 3/7 
activation in RCC4-EV cells (Fig. 4b) within 6 h of exposure to 50 µM propofol. In contrast, significant impact of 
YC-1 on caspase 3/7 activation was not observed in RCC4-VHL cells. Next, RCC4-VHL cells were exposed to the 
HIFα-hydroxylase inhibitors, nPG (100 µM) and DMOG (100 µM). These treatments increased the expression 
of glut1, ldha and pdk1 in RCC4-VHL cells (Fig. 4c). The treatments also significantly suppressed the caspase 3/7 
activation (Fig. 4d) that was induced by 50 µM propofol in RCC4-VHL cells. These findings indicated that HIF 
activation was required and sufficient for establishment of cell protection against propofol-induced toxicity.
Oxygen metabolism in RCC4 cells. Next, we investigated oxygen utilization and glycolysis in RCC4-EV 
and RCC4-VHL cells using the assays measuring OCR by Cell Mito Stress Test (Fig. 5a) and ECAR by Glycolysis 
Stress Test (Fig. 5b). OCR was reduced and ECAR was increased in RCC4-EV cells. The mitochondrial basal 
OCR was significantly lower in RCC4-EV cells than in RCC4-VHL cells in the presence of 20% O2 (Fig. 5c,d). 
The significant differences were also detected in the maximum respiratory rates, non-mitochondrial respiration, 
and proton leak observed in the RCC4-EV and RCC4-VHL cells (Fig. 5e–g). In addition, significant differences 
in mitochondrial mass between RCC4-VHL cells and RCC4-EV cells was observed (Fig. 5h). Thus, we observed 
metabolic reprogramming from aerobic to anaerobic glucose metabolism in the RCC4-EV cells.
The local anesthetic lidocaine induced cell death by targeting mitochondria ETC as well as propofol. To inves-
tigate the mode of targeting of propofol, we examined OCR, which depends on the activity of mitochondrial 
respiratory chain complexes I–IV in membrane-permeabilized and intact cells, using an extracellular flux ana-
lyzer (Supplementary Figure 1). Propofol suppressed ETC complex I, II and III-dependent OCR but lidocaine 
suppressed only complex I (Supplementary Figure 1c,d).
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RNA-Seq analysis of RCC4-EV and RCC4-VHL cells. We conducted a comprehensive gene expression 
analysis using RNA-Seq (Table S1) because a line of reports demonstrated that HIF-1 determines oxygen uti-
lization and glucose metabolism14–16. Our RNA-Seq analysis also made it clear that there are differences in the 
































Figure 1. RCC4-EV cells are more resistant to propofol-induced cell injury than RCC4-VHL cells. RCC4-
VHL and RCC4-EV cells were exposed to the indicated propofol concentrations for 6 h. (a) Cells were 
harvested and cell death was detected by flow cytometry. The ratio of annexin V- and/or PI-positive positive 
cells [(Q1 + Q2 + Q4)/(Q1 + Q2 + Q3 + Q4)] was used to calculate the percentage of dead cells. (b) The cell 
death are shown for each treatment group (n = 3). *p < 0.05, as compared to the control cell population (no 
treatment); #p < 0.05, for the indicated comparison.
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RNA-seq identified differences in the expression levels of selected genes within GO:0061621 (canonical glyc-
olysis) (Fig. 6b) and GO: 0004740 (pyruvate dehydrogenase (acetyl-transferring) kinase activity) (Fig. 6c) in 
these cell lines. To confirm the experimental result of gene expression, we performed meta-analysis using FASTQ 
files deposited in the Sequence Read Archive (https://trace.ddbj.nig.ac.jp/dra/indexe.html) as SRR1554431, 
SRR1554986, SRR1554988 and SRR155499. Comparative analysis of gene expression differences between 
RCC4-EV cells and RCC-VHL cells demonstrated that our study was consistent with the data in SRA except for 
PGK1 (Supplementary Figure 2). This is because the expression intensity of PGK1 was too high and beyond the 
dynamic range of RNA-seq. Thus, the expression difference of PGK1 could not be calculated properly.
ROS generation in RCC4-EV and RCC4-VHL cells in response to propofol treatment. Next, 
we investigated that impact of gene silencing of PDK1 on ROS generation and caspase 3/7 activity in response 
to propofol treatment in RCC4-EV cells. Lack of PDK1 gene expression induced ROS generation and caspase 
3/7 activation (Fig. 7a,b). We found that ROS generation played a critical role in propofol-induced cell death. 
Here, we compared ROS levels in RCC4-VHL and RCC4-EV cells exposed to 50 µM propofol. ROS generation 
in response to 50 µM propofol treatment was observed in RCC4-VHL cells, but not in RCC4-EV cells (Fig. 7c). 
Moreover, treatment with the antioxidant NAC suppressed 50 µM propofol induced caspase 3/7 activation exclu-
sively in RCC4-VHL cells (Fig. 7d,e). Next, we investigated the expression of genes which related to generation 
and scavenging ROS by RNA-Seq analysis. The expression levels of selected genes within GO:0016909 (antioxi-
dant activity) (Fig. 7f) and GO:1903426-8 (regulation of reactive oxygen species biosynthetic process) (Fig. 7g) 
were investigated in these cell lines.
Effect of exogenous HIF-1 activation on propofol toxicity in neuronal SH-SY5Y cells. Finally, 
effect of exogenous HIF-1 activation on propofol-induced toxicity was examined in a different cell-type from 
RCC4 cells. Human neuroblastoma SH-SY5Y cells were treated with 100 µM nPG or 100 µM DMOG in the pres-
ence of 20% O2. The treatments induced expression of HIF-1α protein (Fig. 8a), suppressed OCR, and increased 
ECAR (Fig. 8b) in these cells. Consistent with our findings in RCC4-VHL cells, treatment with nPG or DMOG 
conferred resistance to the caspase 3/7 activation induced by 50 µM propofol (Fig. 8c) and cell death (Fig. 8d).
Discussion
In this study, we demonstrated that activation of HIF-1 by genetic or pharmacological means induced metabolic 











































Figure 2. Propofol-induced caspases activation is attenuated in RCC4-EV cells than RCC4-VHL cells. RCC4-
VHL and RCC4-EV cells were exposed to the indicated propofol concentrations for 6 h. The levels of (a) 
caspase 9 (n = 5) and (b) caspase 3/7 (n = 5) activity are shown for each treatment group. Differences between 
results were evaluated by two-way ANOVA followed by Dunnett’s test for multiple comparisons; *p < 0.05, as 
compared to the control cell population (no treatment); #p < 0.05, for the indicated comparison.
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Figure 3. HIF-1 is activated in RCC4-EV cells under normoxic conditions. (a) 35 µg whole-cell lysates of 
RCC4-EV and RCC4-VHL cells exposed to either 20% O2 or 1% O2 were immunoblotted (IB) using primary 
antibodies raised against the indicated proteins. (b) RCC4-EV and RCC4-VHL cells were cultured with 20% 
O2 prior to analysis of the indicated mRNA levels using semi-quantitative qRT-PCR. Fold expression was 
calculated based on expression in RCC4-VHL cells incubated with 20% O2. Data presented are expressed as 
mean ± SD; #p < 0.05, for the indicated comparison. (c) RCC4-VHL and RCC4-EV cells were cultured for the 
indicated time-periods prior to cell viability evaluation by MTS assay (n = 3). (d) RCC4-VHL and RCC4-EV 
cells were cultured for the indicated time-periods prior to determination of the cellular ATP level. Differences 
between results were evaluated by t-test; #p < 0.05 for the indicated comparison.
www.nature.com/scientificreports/
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of propofol; these effects were observed in both the established renal carcinoma RCC4 cell line and in the neuro-
blastoma SH-SY5Y cell line.
In RCC4 cells, the VHL gene is ablated10. Because VHL is an essential component of the E3 ubiquitin ligase, 
VHL regulates HIFα subunit protein expression9,20. HIF-1 is therefore activated in RCC4-EV cells under both 
20% and 1% O2 conditions. As demonstrated by the present RNA-Seq gene expression analysis, enrichment anal-
ysis, and qRT-PCR study, canonical glycolysis and the HIF-1-dependent pathway were activated in RCC4-EV 
cells. Thus the global gene expression analysis demonstrates change of metabolic mode from OXPHOS to glyco-
lysis in RCC4-EV cells.
O2 is primarily required for OXPHOS within cells. The maximal respiration rates in RCC4-EV cells were 
downregulated, as compared to the rates observed in RCC4-VHL cells. This indicated that mitochondrial elec-
tron transport was significantly inhibited in RCC4-EV, as compared to RCC4-VHL cells. Substrate availability is 
also a critical regulator of OXPHOS. While the most critical substrate for OXPHOS is O2, acetyl-CoA is another 
critical regulator of this process. The conversion of pyruvate to acetyl-CoA thus represents a critical regulatory 
point in cellular energy metabolism17,21. Pyruvate dehydrogenase is regulated by PDK-mediated phosphoryl-
ation of its E1 subunit. PDK1 is downstream of HIF-1 and it negatively regulates mitochondrial function by 
reducing pyruvate entry into the tricarboxylic acid cycle. The present study found that PDK1 mRNA expression 
increased in RCC4-EV cells to a greater extent than in RCC4-VHL or SH-SY5Y cells following treatment with 
HIFα-hydroxylase inhibitors. Suppression of PDK1 expression by siRNA increased ROS in response to propo-
fol treatment. Proton leak, as defined by the mitochondrial respiration rate in the presence of oligomycin, was 
lower in RCC4-EV cells than in RCC4-VHL cells. Mitochondrial superoxide production is highly dependent 
on the membrane potential22,23 and proton leak pathways may therefore minimize oxidative damage by reduc-
ing this potential and thus suppressing superoxide production. Together with metabolic reprogramming, HIF-
1dependent gene expression change contributes to change of mode of electric transport in mitochondria.
Intriguingly, RCC4-EV cells had a higher intracellular ATP concentration than RCC4-VHL cells. This was 
consistent with the more active ECAR in RCC4-EV cells. ECAR provides a surrogate marker of glycolysis21, and 
the higher ECAR in RCC4-EV cells therefore indicated that this ATP was derived from glycolysis. We recently 
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Figure 4. HIF-1 activation is required for RCC4-EV cells and sufficient for RCC4-VHL cells to confer 
resistance against propofol-induced cell death. (a) RCC4-EV and RCC4-VHL cells were incubated with (+) 
or without (−) 100 µM YC-1 for 24 h with 20% O2 prior to analysis of the indicated mRNA levels using qRT-
PCR. Fold expression was calculated relative to the values measured for RCC4-VHL cells incubated with 20% 
O2. Data are expressed as the mean ± SD. Differences between results were evaluated by t-test; #p < 0.05 for the 
indicated comparison. (b) Caspase 3/7 activity in RCC4-EV and RCC4-VHL cells (n = 3), incubated with or 
without 50 µM propofol for 6 h, with or without 100 µM YC-1 as indicated. Differences between results were 
evaluated by two-way ANOVA followed by Dunnett’s test for multiple comparisons; *p < 0.05, as compared to 
the control cells (no treatment); #p < 0.05 for the indicated comparison. (c) RCC4-VHL cells were incubated 
with or without 100 µM nPG or 100 µM DMOG for 24 h, as indicated, prior to determination of the indicated 
mRNA levels by qRT-PCR. Differences between results were evaluated by one-way ANOVA followed by 
Dunnett’s test for multiple comparisons; *p < 0.05, as compared to the control cell population (no treatment). 
(d) Caspase 3/7 activity in RCC4-VHL cells (n = 3) that were exposed to the indicated treatments for 24 h prior 
to treatment with 50 µM propofol for 6 h. Differences between results were evaluated by two-way ANOVA 
followed by Dunnett’s test for multiple comparisons; *p < 0.05, as compared to the control cell population (no 
treatment); #p < 0.05 for the indicated comparison.
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cells in a dose- and time-dependent manner5. Consistent with this conclusion, mitochondrial DNA-deficient 
cells were shown to be resistant to propofol-induced toxicity5. The reduction of O2 to H2O by complex IV is not 
completely efficient. If electron transfer to O2 occurs at complexes I or III, ROS generation occurs and these free 
radicals can oxidize cellular proteins, lipids, and nucleic acids. The ROS plays a critical role in propofol-induced 
cell death. In fact, the treatment with the antioxidant NAC reduced propofol-induced caspase 3/7 activation. 
Propofol induced significantly less ROS production in RCC4-EV cells than in RCC4-VHL cells. Propofol has also 
been shown to suppress the activity of complexes I, II and III, and to reduce mitochondrial oxygen consumption5. 
The RNA-Seq analysis indicated that HIF-1 activation on RCC4-EV cells induced gene expression which facilitate 
glycolysis but not significantly induced gene sets of peroxidase activity or reactive oxygen species metabolic pro-
cess. Thus, HIF target gene activation is upstream of mitochondrial function and can alter mitochondrial activity.
Preclinical studies in animal models have predicted that systemic HIF activation has the potential to alter glu-
cose, fat, and mitochondrial metabolism24. Indeed, a series of HIFα-hydroxylase inhibitors are currently under-
going evaluation in clinical anemia trials25,26. Thus, in addition to nPG and DMOG, these HIFα-hydroxylase 
inhibitors could modulate mitochondrial metabolism and may prevent the cell death that occurs during propofol 
infusion syndrome. The findings of the present study warrant a preclinical trial of these inhibitors for the treat-
ment of this syndrome in an animal model.
In conclusion, VHL deletion or exposure to small-molecule HIFα-hydroxylase inhibitors activates HIF-1 and 
cellular metabolic reprogramming and oxygen utilization of mitochondria. The HIF-1 activation suppresses ROS 
generation and confers resistance to propofol toxicity.
Materials and Methods
Cell culture and reagents. Renal cell carcinoma cell lines were stably transfected with pcDNA3-VHL 
(RCC4-VHL) or empty vector (RCC4-EV)6. These cells lines were maintained in Dulbecco’s modified Eagle’s 
medium supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 0.1 mg/ml streptomycin. The 
human neuroblastoma SH-SY5Y cells were maintained in RPMI medium supplemented with 10% fetal bovine 
Figure 5. Reprogrammed oxygen metabolism in RCC4-EV cells. OCR (a) and ECAR (b) in the indicated cells 
under normoxic (20% O2) conditions. (c) Cell Mito Stress test™ profile of the key parameters of mitochondrial 
oxygen consumption rate (OCR). The values of basal OCR (d), maximal OCR (e), the non-mitochondrial 
respiration rate (f), and proton leakage (g) are also indicated for RCC4-EV and RCC4-VHL cells. (h) Equal 
numbers of RCC4 and RCC4- VHL cells were stained with MitoTracker™ Green FM and analyzed by flow 
cytometry to measure mitochondrial mass. Differences between results were evaluated by t-test #p < 0.05 
compared to the control cell population (group).
www.nature.com/scientificreports/
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serum, 100 U/ml penicillin, and 0.1 mg/ml streptomycin6,27,28. Purified mouse anti-human HIF-1α antibody 
Clone 54/HIF-1α was purchased from BD Biosciences (San Jose, CA). HIF-1β/ARNT (D28F3) XP rabbit mon-
oclonal antibody was from Cell Signaling Technology (Danvers, MA). Dimethyloxaloylglycine (DMOG) and 
n-propyl gallate (nPG) the anti-β-actin antibody were obtained from Sigma. A list of reagents used in this study 
is provided in Table 1.
Cell growth assay. Cell growth was assessed using a CellTiter 96™ AQueous One Solution Cell Proliferation 
Assay (Promega, Madison, WI, USA)6,28. This assay measured the reduction of the tetrazolium compound, MTS 
(3-[4,5-dimethyl-2-yl]-5-[3-carboxymethoxyphenyl]-2-[4-sulfophenyl]-2H-tetrazolium, inner salt). Briefly, 
cells were seeded into 96-well plates (3 × 103 cells/well) and cultivated for 24, 48 and 72 h. 20 μl of CellTiter 96 
AQueous One Solution™ Reagent was added to each well and the plates were incubated at 37 °C for 1 h prior to 
measuring the absorbance of each sample using an iMark™ Microplate Reader (BIO-RAD, Hercules, CA, USA) 
at a wavelength of 490 nm. Cell viability was then calculated by comparing the absorbance of the treated cells 
with that of the control cells (RCC4-VHL cells at 24 h incubation), which was defined as 100%. All samples were 
assayed in triplicate or quadruplicate for each experiment.
Reagents Identifier Source
Dulbecco’s modified Eagle’s medium 11965-092
Thermo Fisher Scientific, Waltham, MA, USARPMI medium 11875-093
MitoTracker™ Green FM M7514
fetal bovine serum SH30910
GE Healthcare, Little Chalfont, UKHorseradish peroxidase-conjugated sheep anti-mouse IgG NA931
ECL prime enhanced chemiluminescence reagent RPN2232
penicillin-streptomycin 09367-34







succinic acid disodium salt 32405-62




albumin from bovine serum (BSA) 017-15141
adenosine 5′-diphosphate, monopotassium salt (ADP) 303-50751
N,N,N′,N′-tetramethyl-p-phenylenediamine (TMPD) 203-12821
Dimethyloxaloylglycine (DMOG) D3695
SIGMA, St Louis, MO, USA
n-propyl gallate (nPG) P3130
oligomycin O4876
carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP) C2920
rotenone R8875
antimycin A A8674
CellTiter 96™ AQueous One Solution Cell Proliferation Assay G3582
Promega, Madison, WI, USA
Caspase-Glo™ 9 Assay Kit G8210
Apo-ONE™ Homogeneous Caspase-3/7 Assay Kit G7792
CellTiter-Glo™ luminescent cell viability assay kit G7570
RNeasy™ Mini Kit 74104
Qiagen, Hilden, GermanyQuantiTect™ Reverse Transcription Kit 205311
Rotor-Gene™ SYBR Green PCR Kit 204074
anti-human HIF-1α antibody Clone 54/HIF-1α 610959 BD Biosciences, San Jose, CA, USA
HIF-1β/ARNT (D28F3) XP rabbit monoclonal antibody 5537 Cell Signaling Technology, Danvers, MA, USA
Complete Protease Inhibitor 4693116001 Roche Diagnostics, Tokyo, Japan
Annexin V-FITC Apoptosis Detection Kit K101 BioVision, Milpitas, CA, USA
Seahorse XF Plasma Membrane Permeabilizer (PMP) 102504-100 Agilent Technologies, Santa Clara, CA, USA
tetramethylhydroquinone (duroquinol) T0822 Tokyo Chemical Industry, Tokyo, Japan
2′,7′-dichlorofluorescin diacetate (DCFH-DA) D399 Molecular Probes, Eugene, OR, USA
Table 1. Key Resources Table.
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Caspase activity assays. The levels of caspase 9 and caspase 3/7 activity were assessed using a 
Caspase-Glo™ 9 Assay Kit (Promega) and an Apo-ONE™ Homogeneous Caspase-3/7 Assay Kit (Promega), 
respectively, according to the manufacturer’s protocols6,28. Briefly, cells were seeded into 96-well plates (2 × 104 
cells/well) and incubated overnight. The following day, cells were treated with the indicated concentrations of 
the appropriate drug(s) for varying lengths of time. After treatment, 100 μl of Apo-ONE Caspase-3/7 Reagent™ 
was added to each well. Cells were incubated at room temperature for 1 h and the luminescence of each well was 
measured using an EnSpire™ Multimode Plate Reader (PerkinElmer, Waltham, MA, USA). Caspase activity was 
then calculated by comparing the levels of luminescence of the treated cells with that of the control cells (incu-
bated without drugs), which was defined as 100%. Assays were performed in triplicate at least twice. Data were 
expressed as means ± the standard deviation (SD).
Immunoblot assays. Whole-cell lysates were prepared as described previously6,27,29. In brief, these were 
prepared using ice-cold lysis buffer containing 0.1% sodium dodecyl sulfate, 1% Nonidet P-40, 5 mM eth-
ylenediaminetetraacetic acid, 150 mM NaCl, 50 mM Tris-Cl (pH 8.0), 2 mM dithiothreitol, 1 mM sodium 
orthovanadate, and Complete Protease Inhibitor™ (Roche Diagnostics, Tokyo, Japan). Samples were centri-
fuged at 10,000 × g to sediment the cell debris, and the supernatant was used for subsequent immunoblotting 
experiments. For HIF-1α and HIF-1β determinations, 35 µg of protein was fractionated by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (7.5% gel), transferred to membranes, and immunoblotted using the 
indicated primary antibodies at a dilution of 1:500. Horseradish peroxidase-conjugated sheep anti-mouse IgG 
(GE Healthcare, Piscataway, NJ) was used as the secondary antibody, at a dilution of 1:2,000. The signal was 
developed using enhanced chemiluminescence reagent (GE Healthcare). Experiments were repeated at least 
three times and representative blots are shown.
Figure 6. Gene set enrichment analysis of RCC4 cells. (a) A heatmap of enriched terms across the input gene 
lists, colored to indicate the p values. Cuffdiff and Metascape were used for this analysis. RNA-seq analysis of the 
expression levels of selected genes within (b) GO:0061621 (canonical glycolysis) and (c) GO:0004740 (pyruvate 
dehydrogenase (acetyl-transferring) kinase activity) in RCC4-EV and RCC4-VHL cells. The y axis indicates the 
ratio of the average FPKM values for RCC4-VHL cells.
www.nature.com/scientificreports/
1 0SCIEnTIfIC RePORTS |  (2018) 8:8987  | DOI:10.1038/s41598-018-27220-8
Analysis of cell death. Cell death was investigated using a previously described protocol6,28. Briefly, apopto-
sis was measured using an Annexin V-FITC Apoptosis Detection Kit (BioVision, Milpitas, CA, USA), according 
to the manufacturer’s instructions. For these analyses, cells were seeded into 6-well plates (3 × 105 cells/well) and 
incubated overnight. The following day, cells were treated with the indicated concentrations of the appropriate 
drug(s) for varying lengths of time prior to harvesting by centrifugation at 1,200 rpm for 3 min. The culture 
supernatants were discarded and the pellets were resuspended in a mixture of 500 μl binding buffer, 5 μl annexin 
V-fluorescein isothiocyanate (FITC), and 5 μl propidium iodide (PI; 50 μg/ml) for 5 min at room temperature in 
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Figure 7. ROS production in response to propofol treatment is reduced in RCC4-EV cells. (a and b) RCC4-EV 
cells were transfected with small interfering RNA (siRNA) targeting pyruvate dehydrogenase kinases 1 (PDK-1) 
or a negative control (scr). Cells were exposed to 50 µM propofol and ROS generation (a) and caspase 3/7 (b) 
were assayed. (c) ROS generation in RCC4-VHL cells and RCC4-EV cells exposed to 50 µM propofol (n = 3) 
were assayed. (d and e) RCC4-EV (d) and RCC4-VHL (e) cells were exposed to 50 µM propofol for 6 h with or 
without 10 mM NAC treatment. Caspase 3/7 activity of the cells were assayed. Differences were evaluated by 
two-way ANOVA followed by Dunnett’s test for multiple comparisons; *p < 0.05, as compared to the control 
cells (no treatment); #p < 0.05 for the indicated comparison. (f and g) RNA-seq analysis of the expression levels 
of selected genes within (f) GO:0016909 (antioxidant activity) and (g) GO:1903426-8 (regulation of reactive 
oxygen species biosynthetic process) in RCC4-EV and RCC4-VHL cells. The y axis indicates the ratio of the 
average FPKM values for RCC4-VHL cells.
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Figure 8. Forced HIF-1 activation is sufficient to resist propofol toxicity in SH-SY5Y neuroblastoma cells. (a) 
SH-SY5Y cells were incubated with (+) or without (−) 200 µM nPG or 1 mM DMOG for 4 h. 35 µg of whole-cell 
lysates were immunoblotted (IB) using primary antibodies raised against the indicated proteins. (b) OCR and 
ECAR were measured in SH-SY5Y cells exposed to 100 µM nPG or 100 µM DMOG for 4 h. (c and d) SH-SY5Y 
cells were exposed to 100 µM nPG and 100 µM DMOG for 4 h and then exposed to 50 µM propofol for 6 h. 
Graphic depictions of caspase-3/7 activity (n = 3) (c) and cell death (n = 3) (d). Differences were evaluated by 
two-way ANOVA followed by Dunnett’s test for multiple comparisons; *p < 0.05, as compared to the control 
cells (no treatment); #p < 0.05 for the indicated comparison.
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with CellQuest Pro™ software. Data were evaluated using FlowJo™ version 7.6.3 software (TreeStar, Ashland, 
OR, USA), exported to Excel spreadsheets, and subsequently analyzed using the statistical application, Prism7™.
ATP assay. The CellTiter-Glo™ luminescent cell viability assay kit (Promega, Madison, WI) was used to 
evaluate the intracellular ATP content6. Briefly, cells were seeded in 96-well plates (3 × 103 cells/well) and allowed 
to grow for 24, 48 and 72 h. CellTiter-Glo reagent (50 μl) was then added directly into each well and incubated for 
10 min prior to reading the plate using an EnSpire™ Multimode Plate Reader (PerkinElmer, Waltham, MA, USA). 
This detected the luminescence generated by the luciferase-catalyzed reaction between luciferin and ATP. Assays 
were performed in triplicate at least twice. The ATP content was then calculated by comparing the luminescence 
levels of RCC4-VHL cells with that of RCC4-EV cells, which was defined as 100%. Data were expressed as the 
mean ± SD.
Measurement of cellular oxygen consumption and extracellular acidification. The cellu-
lar oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were respectively detected 
by the XF Cell Mito Stress Test™ and XF Glycolysis Stress Test™ using a XFp Extracellular Flux Analyzer™ 
(Agilent Technologies, Santa Clara, CA)6. RCC4-EV and RCC4-VHL cells were seeded onto the XFp Cell 
Culture microplate at a density of 1 × 104 cells/well. The XF Cell Mito Stress Test™ for OCR was assessed in 
glucose-containing XF base medium, according to the manufacturer’s instructions. The sensor cartridge for the 
XFp analyzer was hydrated at 37 °C in a non-CO2 incubator one day before the experiment. For the OCR assay, 
the injection port A on the sensor cartridge was loaded with oligomycin (a complex V inhibitor, final concentra-
tion 1 µM), carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP; an uncoupling agent, final concentra-
tion 2 µM) was loaded to port B, and rotenone/antimycin A (inhibitors of complexes I and III, final concentration 
0.5 µM each) was loaded to port C. During the sensor calibration, cells were incubated at 37 °C in the non-CO2 
incubator in 180 μl assay medium (XF Base Medium, 25 mM glucose, 1 mM pyruvate, and 2 mM l-glutamine, pH 
7.4). The plate was immediately placed onto the calibrated XFp Extracellular Flux Analyzer for the assay.
The minimum OCR measured after rotenone/antimycin A injection was considered to represent the 
non-mitochondrial respiration rate. The basal OCR was calculated by subtracting the non-mitochondrial res-
piration rate from the last OCR measurement before oligomycin injection. The maximal OCR was calculated by 
subtracting the non-mitochondrial respiration rate from the maximum OCR measurement after FCCP injection. 
The proton leakage was calculated by subtracting the non-mitochondrial respiration rate from the minimum 
OCR measured after oligomycin injection.
For XF Glycolysis Stress Test™ for the ECAR, injection port A on the sensor cartridge was loaded with glucose 
(final concentration 10 mM), 2-Deoxy-D-glucose (final concentration 50 mM) loaded to portB and olygomycin 
(final concentration 1 µM) was loaded to port C. During the sensor calibration, cells were incubated at 37 °C in 
180 μl assay medium (XF Base Medium and 2 mM l-glutamine, pH 7.4) in the non-CO2 incubator. The plate was 
immediately placed into the calibrated XFp Extracellular Flux Analyzer for the assay.
Measurement of oxygen consumption in permeabilized cells. The activity of individual res-
piratory chain complexes was evaluated in permeabilized cells30,31. Briefly, cells were washed with mitochon-
drial assay solution (MAS) buffer (220 mM mannitol, 70 mM sucrose, 10 mM KH2PO4, 5 mM MgCl2, 2 mM 
HEPES, 1 mM EGTA, 0.2% fatty acid-free bovine albumin, adjusted to pH 7.2 with KOH), and the medium 
was replaced with MAS buffer supplemented with 10 mM pyruvate, 1 mM malate, 4 mM ADP, and 1 nM plasma 
membrane permeabilizer™. The cells were then loaded into the XFp analyzer to measure respiration rates using 
cycles of 30 s mixing/30 s waiting/2 min measurement. Protocol A: After the measurement of pyruvate-driven 
respiration, rotenone (final concentration 2 µM) was injected through port A to halt the complex I-mediated 
respiratory activity. Next, succinate (10 mM) was injected through port B to donate electrons at complex II, 
bypassing complex I inhibition. The addition of antimycin A (2 µM) via port C inhibited complex III, and N,N,
N′,N′-tetramethyl-p-phenylenediamine (TMPD 0.1 mM), combined with ascorbate (10 mM), was subsequently 
injected through port D to measure complex IV activity. Protocol B: As an alternative approach, cells were ini-
tially supplemented with pyruvate to measure complex I activity. After injection of rotenone, duroquinol was 
injected to stimulate complex III-mediated respiration.
Mitochondrial mass assay. Mitochondrial mass was measured by staining cells with MitoTracker™ Green 
FM at 37 °C for 15 min in PBS containing 5% FBS. Stained cells were filtered and analyzed immediately in a 
FACScan flow cytometer (BD Bioscience). Mean fluorescence intensity was analyzed using CellQuest software 
(BD Bioscience).
Semi-quantitative real-time reverse transcriptase-polymerase chain reaction analysis 
(qRT-PCR). Total RNA was extracted from cells using the RNeasy™ Mini Kit (Qiagen, Hilden, Germany), 
according to the manufacturer’s instructions6. First-strand synthesis and RT-PCR were performed using the 
QuantiTect™ Reverse Transcription Kit (Qiagen) and Rotor-Gene™ SYBR Green PCR Kit (Qiagen), according to 
the manufacturer’s protocol. Amplification and detection were performed using Rotor-Gene™ Q (Qiagen). PCR 
primers were purchased from Qiagen. The change in expression of each target mRNA was calculated relative to 
the level of 18S rRNA.
Measurement of ROS generation. ROS generation was detected using 2′,7′-dichlorofluorescin diacetate 
(DCFH-DA) (Molecular Probes, Eugene, OR). Briefly, cells were cultured in 35-mm diameter glass-bottomed 
culture dishes (MatTek, Ashland, MA) and incubated with 10 µM DCFH-DA for 10 min at 37 °C in serum-free 
Dulbecco’s modified Eagle’s medium. The cells were then washed twice with Dulbecco’s phosphate-buffered saline 
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and analyzed using a flow cytometer (Becton Dickinson, San Jose, CA)32. Mean fluorescence intensity was ana-
lyzed using CellQuest software (Becton Dickinson).
RNA-Seq protocol. Total RNA was extracted from RCC4-EV and RCC4-VHL cells using RNeasy Mini Kit 
(Qiagen). RNA-Seq libraries were prepared using TruSeq Stranded mRNA Sample Prep Kit for Illumina multi-
plexed sequencing (Illumina, San Diego, CA, USA). TruSeq stranded mRNA library preparation kit was used to 
generate poly (A) RNA libraries for RNA obtained from normal skin samples (Illumina, San Diego, CA, USA). 
Libraries were sequenced (100 bp, paired-end) on the Illumina HiSeq2500 platform. The sequence data (FASTQ 
files)were deposited in the DDBJ Sequence Read Archive under accession numbers DRR100656 and DRR100657, 
respectively.
RNA-Seq data analysis. FASTQ files for RCC4-EV cells (DRR100656) and RCC4-VHL cells (DRR100657) 
were evaluated by FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) after the trimming pro-
cess by FASTX-Toolkit v0.0.14 (http://hannonlab.cshl.edu/fastx_toolkit/). The human reference sequence file 
(hs37d5.fa) was downloaded from the 1000 Genomes Project ftp site (ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/
technical/reference/phase2_reference_assembly_sequence/), and the annotated general feature format (gff) file 
was downloaded from the Illumina iGenome ftp site (ftp://igenome:G3nom3s4u@ussd-ftp.illumina.com/Homo_
sapiens/NCBI/build37.2/). The human genome index was constructed with bowtie-build in Bowtie v.2.2.933. 
The FASTQ files were aligned to the reference genomic sequence by TopHat v.2.1.1, with default parameters34. 
Bowtie2 v2.2.9 and Samtools v.1.3.1 were used within the TopHat program35. The estimated transcript abundance 
was calculated, and the count values were normalized to the upper quartile of the fragments per kilobase of tran-
script per million mapped reads (FPKM) using Cufflinks (Cuffdiff) v2.1.136.
Metascape (http://metascape.org/) was used for the gene set enrichment analysis37. A gene list for Metascape 
analysis was generated from the Cuffdiff output, where 235 genes were identified as ‘significantly differentially 
expressed’ (p < 0.05; Table S1).
Genes with the gene ontology (GO) annotations of ‘canonical glycolysis’ (GO:0061621), ‘pyruvate dehydroge-
nase (acetyl-transferring) kinase activity’ (GO:0004740), ‘antioxidant activity’ (GO:0016909) and ‘regulation of 
reactive oxygen species biosynthetic process’ (GO:1903426-8) were extracted using Ensembl Biomart38 and sorted 
by the common logarithms of ([FPKM of RCC4-EV] + 1)/([FPKM of RCC4-VHL] + 1), calculated from the same 
Cuffdiff output file (Table S1). We added 1 to the FPKM values because it is not possible to calculate the logarithm 
of 0. A histogram was generated using TIBCO Spotfire Desktop v7.6.0 with the “Better World” program license 
(TIBCO Spotfire, Inc., Palo Alto, CA, USA) (http://spotfire.tibco.com/better-world-donation-program/).
Statistical analysis. All experiments were repeated at least twice and each sample was evaluated in tripli-
cate. Data are expressed as the mean ± SD. Differences between results were evaluated by one-way analysis of var-
iance (ANOVA), two-way ANOVA followed by Dunnett’s test for multiple comparisons, or t-test using Prism7™ 
(GraphPad Software, Inc. La Jolla, CA). P-values < 0.05 were considered statistically significant6,28.
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